- Home
- DOX vs AXSM Comparison
DOX vs AXSM Comparison
Compare DOX & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DOX | AXSM |
|---|---|---|
| Founded | 1982 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 9.0B |
| IPO Year | 1998 | 2015 |
Fundamental Metrics
Financial Performance| Metric | DOX | AXSM |
|---|---|---|
| Price | $82.34 | $188.20 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 21 |
| Target Price | $97.00 | ★ $190.57 |
| AVG Volume (30 Days) | ★ 891.4K | 876.5K |
| Earning Date | 02-03-2026 | 02-23-2026 |
| Dividend Yield | ★ 2.53% | N/A |
| EPS Growth | ★ 19.01 | N/A |
| EPS | ★ 5.05 | N/A |
| Revenue | ★ $4,532,913,000.00 | $561,263,000.00 |
| Revenue This Year | $4.57 | $67.43 |
| Revenue Next Year | $4.11 | $58.11 |
| P/E Ratio | $16.51 | ★ N/A |
| Revenue Growth | N/A | ★ 65.83 |
| 52 Week Low | $74.32 | $86.99 |
| 52 Week High | $95.41 | $191.50 |
Technical Indicators
Market Signals| Indicator | DOX | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 51.27 | 68.04 |
| Support Level | $82.23 | $172.05 |
| Resistance Level | $83.99 | $191.50 |
| Average True Range (ATR) | 1.42 | 5.77 |
| MACD | -0.19 | 0.50 |
| Stochastic Oscillator | 15.54 | 87.30 |
Price Performance
Historical ComparisonAbout DOX Amdocs Limited
Amdocs Ltd is a provider of software and services to communications, cable and satellite, entertainment, and media industry service providers. The Company and its subsidiaries operate in one operating segment, providing software products and services for the communications, entertainment and media industry service being designed, develop, market, support, implement, and operate its open and modular cloud offering. The company offers business support systems, operational support systems, and managed services. Geographically, it derives a majority of revenue from North America and also has a presence in Europe and the Rest of the world.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.